Skip to main content

Antibe Therapeutics Inc(ATE-T)
TSX

Today's Change
Real-Time Last Update

Antibe Therapeutics: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (ATE)

The Globe and Mail - Mon Jan 23, 2023
Industry Group

Antibe Therapeutics is now ranked among the top 10 undervalued stocks in the Medical Devices & Instruments industry on the Toronto Stock Exchange or TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company. Valuation methodology provided by Stockcalc (see below).

Medical Devices & Instruments: Companies that develop, manufacture, and market medical and surgical equipment and machinery, including orthopedic products, respiratory care equipment, x-ray equipment, laser systems, implants, pacemakers, and other major medical machines and apparatus. Stocks in this category are held primarily for capital appreciation.

SymbolNameClose Price ($)Valuation ($)DifferenceAverage Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
MDX-XMedx Health0.050.060.01
(15.6)
42,2379.200
LBL-H-XLattice Biologics0.040.040
(6.43)
05.100
ATE-TAntibe Therapeutics0.61.070.47
(79.05)
35,47131.300
QIPT-XQuipt Home Medical8.029.041.02
(12.77)
83,447298.5045.8
SGMD-XSalona Global Medical0.490.520.03
(6.32)
88,0652700
IDL-XImaging Dynamics Co0.170.180.01
(6.08)
1841.800
VMD-TViemed Healthcare10.5411.250.71
(6.72)
17,737417.2041.2
CHIP-H-XHealth Logic Interactive0.030.070.04
(136.32)
9340.200
NGMD-XNuGen Medical Devices0.040.070.02
(51.86)
30,117400
PINK-XPerimeter Medical Imaging1.732.370.64
(36.76)
22,588110.700

More about Antibe Therapeutics

All data provided as-at market close January 19, 2023. The list is sorted by stocks with the greatest percentage difference between valuation and price. Antibe Therapeutics Antibe Therapeutics Inc is a healthcare company. It is engaged in the development of patents and out-licensing of improved compounds of existing drugs. The company has two primary business segments: Antibe Therapeutics and Citagenix. Antibe Therapeutics is listed under ATE on the Toronto Stock Exchange.

Stockcalc

StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs. StockCalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. StockCalc's Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including: Discounted Cash Flow (DCF), Price & Other Comparables, Multiples, Adjusted Book Value (ABV) and Analyst Consensus

Artificial intelligence at Report on Business

Artificial Intelligence at Report on Business Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.

More from The Globe

watchlist
25 stocks most added to Watchlists